ArticleFuture science OA2023

The soluble suppression of tumorigenicity 2 as a biomarker of early cardiac remodeling in bradycardia patients receiving permanent pacemaker therapy.

Mohammad Iqbal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.